Home Top Movers Companies Concepts

Market

Top Movers
Companies
Concepts

SEC Filings

AI Filing Analysis
Financial Reports
Current Reports
IPO Filings

Ownership

Institutional Holdings
Insider Trading

About

Data updates every 5 min
SEC EDGAR Source

© 2025–2026 StockGist|Information only, not investment advice

SCHEDULE 13G/A - ArriVent BioPharma, Inc. Common Stock | StockGist | StockGist

Companies
AVBP
SCHEDULE 13G/A

Home Top Movers Companies Concepts

Home Filings AVBPSCHEDULE 13G/A

SCHEDULE 13G/A

Beneficial Ownership

Amendment

ArriVent BioPharma, Inc. Common Stock

Filed Nov 5, 2025

Accepted Nov 4, 2025, 7:00 PM ET

CIK 0001868279

View on SEC.gov Company Profile

Beneficial Ownership Report

Passive Investment

% of Class

49.00%

Shares Owned

315,066

Reporting Person

ArriVent BioPharma, Inc.

Person Type

HC

CUSIP: 04272N102

Amendment History

6 filings

SCHEDULE 13G
Original
Oct 30, 20250000102909-25-000025
SCHEDULE 13G/A
Amendment 1
Aug 13, 20250000919574-25-004712
SCHEDULE 13G/A
Amendment 2
Aug 14, 20250001415889-25-021943
SCHEDULE 13G/A
Amendment 3
Oct 17, 20250002012383-25-002500
SCHEDULE 13G/A
Amendment 4
Viewing
Nov 5, 20250000315066-25-002677
SCHEDULE 13G/A
Amendment 5
Latest
Nov 14, 20250001214659-25-016716

Key Facts

% of Class

49.00%

Shares Owned

315,066

Recent Filings

ArriVent BioPharma, Inc. Common Stock1 months ago

ArriVent BioPharma, Inc. Common Stock1 months ago

ArriVent BioPharma, Inc. Common Stock1 months ago

ArriVent BioPharma, Inc. Common Stock1 months ago

ArriVent BioPharma, Inc. Common Stock1 months ago

Data Sources

Original SEC Filing SEC EDGAR Company Page

Market

Top Movers
Companies
Concepts

SEC Filings

AI Filing Analysis
Financial Reports
Current Reports
IPO Filings

Ownership

Institutional Holdings
Insider Trading

About

Data updates every 5 min
SEC EDGAR Source

© 2025–2026 StockGist|Information only, not investment advice